"MNGI Digestive Health (previously Minnesota Gastroenterology) specializes in the diagnosis and treatment of adults and children with GI disorders. Our board-certified gastroenterologists have expertise in virtually all types of digestive conditions, such as acid reflux disease, heartburn and swallowing disorders, Crohn's disease and ulcerative colitis, hepatitis and liver disease, biologics and infusion therapy, celiac disease, hemorrhoid banding and more."

During the past decade, Minnesota Gastroenterology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minnesota Gastroenterology" #1 sponsor was "Celgene" with 3 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Ception Therapeutics" with 2 trials sponsored, "Bell International Laboratories" with 1 trials sponsored and "Beth Israel Deaconess Medical Center" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minnesota Gastroenterology" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator, "Advocate Health Care" with 1 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Allina Health System" with 1 trials as a collaborator and "Atlanta Gastroenterology Associates" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Minnesota Gastroenterology" are "Eosinophilic Esophagitis" (5 trials), "Ulcerative Colitis" (5 trials), "Crohn's Disease" (2 trials), "Advanced Fibrosis" (1 trials) and "Cirrhosis" (1 trials). Many other conditions were trialed in "Minnesota Gastroenterology" in a lesser frequency.

Most popular intervention types in "Minnesota Gastroenterology" are "Drug" (12 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CC-93538" (2 trials), "Mirikizumab" (2 trials), "Administration of Lactated Ringer's (LR) Solution" (1 trials) and "Colchicine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Minnesota Gastroenterology" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Minnesota Gastroenterology". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Minnesota Gastroenterology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Minnesota Gastroenterology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".